Recursion Pharmaceuticals, Inc. (RXRX)
3.38
-0.08
(-2.31%)
USD |
NASDAQ |
May 01, 16:00
3.42
+0.04
(+1.18%)
After-Hours: 20:00
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.2053 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Tango Therapeutics, Inc. | -0.2945 |
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Quince Therapeutics, Inc. | -7.081 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.12M |
| Revenue (Quarterly) | 35.54M |
| Total Expenses (Quarterly) | 143.66M |
| Enterprise Value | 1.158B |
| Gross Profit Margin (Quarterly) | 24.37% |
| Profit Margin (Quarterly) | -304.2% |
| Earnings Yield | -43.87% |
| Normalized Earnings Yield | -43.87 |